Equity
€126,999 ▼ 44.0%
Nutrifocus paid out €62,444 in dividends in a year with a loss of €37,428.
Nutrifocus
Lifetime
4 annual accounts with figures on one time axispeak €128,739 (2023)
-€16,787▼ €83,817
lowest -€37,428 (2025)
-€37,428▼ €83,272
peak €226,871 (2024)
€126,999▼ 44.0%
€76,048▲ 67.3%
Board1 name since 2021
1 director
Documentsfilings and deeds
19-05-202673 days before the deadline
2025micro format
Gross margin from €67,030 to -€16,787Loss of €37,428Dividend €62,444Equity from €226,871 to €126,999Debts from €45,468 to €76,048
Key points
from the 2025 annual accountsResult
-€37,428 -€37,428
From profit to loss in 2025, after a profit of €45,844 in 2024.
Liquidity
2.44 was 5.37 in 2024
Short-term debts rose from €45,468 to €76,048.
Filings
4 annual accounts 3 late
The 2023 accounts came latest: 30 days after the end of the period.
Starting capital
€180 180 shares
Position in the sector
-€37,428
Lower net result than 88% of companies in research and development. Sector median €23,796 · 668 companies.
Turnover not published (micro format)
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 3,592 companies had the same profile as Nutrifocus has now. Each dot stands for 9 companies, two years later.
87.4%
were still trading
9.4%
stopped another way
3.0%
went bankrupt
Another 0.3% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,331 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 3,592 companies, not a prediction for Nutrifocus. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0770458231
Incorporation
Founding capital of €180, 180 shares · Founder: · Appointment: (sole director) · published on 01-07-2021 · Gazette deed
First establishment
Douglaslaan 25, Kapellen
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| Nutrifocus Kapellen | €203,047 | -€16,787 | 62.5% | - |
| Arquebus Solutions Europe Machelen (Brab.) | €186,058 | -€7,746 | -30.7% | - |
| GRAND MEDICAL (EUROPE) Niel | €135,260 | -€79,756 | -1057.7% | 0.4 |
| IDRO Antwerp | €234,400 | €1,874 | -132.1% | 2.5 |
| MENTANA DX Evergem | €229,998 | -€33,226 | 99.4% | - |
| HEALYS Kortenberg | €221,419 | -€12,824 | 72.1% | - |
| VERBO CLINICAL QUALITY ASSURANCE Ypres | €157,880 | -€6,539 | 92.9% | - |
These companies have the same main activity as Nutrifocus: research and development on biotechnology (NACE 72101). They are comparable in size and age: total assets between €135,000 and €234,000, founded between 2020 and 2022.
Official details
Source: KBO- Status
- Active since 29-06-2021Normal situation
- Activity
- Research and development on biotechnologyNACE 72101and 1 other
- Establishment unit
- 2.318.956.5312950 Kapellen, since 29-06-2021
- Financial year end
- 31 December
- Peppol
- Reachable since 03-10-2025
Annual accounts 2025
- €203,047▼ 25.4%
- Filing
- Filed on 19-05-2026, 73 days before the end of the filing period
Insights on Nutrifocus
Nutrifocus files the micro format. That format states no turnover. The gross margin fell from €113,592 in 2022 to -€16,787 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about Nutrifocus
- What is the company number of Nutrifocus?
- The company number of Nutrifocus is 0770.458.231. The VAT number is the same number with BE in front: BE 0770.458.231.
- Where is Nutrifocus based?
- The registered office is at Douglaslaan 25, 2950 Kapellen.Company details
- What does Nutrifocus do?
- According to the KBO register, the main activity is research and development on biotechnology (NACE 72101).
- What is the legal form of Nutrifocus?
- Nutrifocus is a private limited company (BV).
- When was Nutrifocus founded?
- Nutrifocus was founded on 29-06-2021.
- Is Nutrifocus still active?
- Yes, Nutrifocus is an active enterprise in the KBO register.
- What is the turnover of Nutrifocus?
- The annual accounts for financial year 2025 state no turnover. The micro format does not require it.Financials
- Is Nutrifocus profitable?
- In financial year 2025, Nutrifocus made a loss of €37,428.
- Where can I find the annual accounts of Nutrifocus?
- Nutrifocus filed 4 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of Nutrifocus due?
- Nutrifocus must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check See which support similar companies received that this one did not.Subsidies Compare this company with its sector.Sector benchmark
See how customers, suppliers and banks see your own company and what to improve first.